Reference
Kong G, et al. Initial experience with gallium-68 DOTA-Octreotate PET/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma. Journal of Pediatric Hematology/Oncology 38: 87-96, No. 2, Mar 2016. Available from: URL: http://doi.org/10.1097/MPH.0000000000000411 - Australia
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1599, 27 (2016). https://doi.org/10.1007/s40278-016-16890-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-16890-8